Jazz Pharmaceuticals (JAZZ) Share-based Compensation (QoQ) (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) Share-based Compensation (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Jazz Pharmaceuticals | 15.78 Bn | 13.93 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.15% |
| Dec 31, 2025 | -53.04% |
| Sep 30, 2025 | 8,712.32% |
| Jun 30, 2025 | -97.47% |
| Mar 31, 2025 | 1,590.39% |
| Dec 31, 2024 | 106.22% |
| Sep 30, 2024 | -213.58% |
| Jun 30, 2024 | -7.79% |
| Mar 31, 2024 | 16.06% |
| Dec 31, 2023 | -58.13% |
| Sep 30, 2023 | 1,521.06% |
| Jun 30, 2023 | -115.79% |
| Mar 31, 2023 | 149.00% |
| Dec 31, 2022 | -195.53% |
| Sep 30, 2022 | 1,303.13% |
| Jun 30, 2022 | -119.98% |
| Mar 31, 2022 | -5.74% |
| Dec 31, 2021 | -51.14% |
| Sep 30, 2021 | 3,108.83% |
| Jun 30, 2021 | -85.76% |